Sort by
Refine Your Search
-
Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics/epitranscriptomics (RNA modifications) and RNA-based
-
pertinent clinical and protocol information on request forms. Develop and maintain knowledge of various aspects of processing specimens, with particular attention to safety practices. Identify and communicate
-
. The ideal candidate will have experience in developing LC-MS-based methods, troubleshooting instrumentation, processing complex data, and creating SOPs for metabolite and lipid identification. As a successful
-
candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation
-
modify protocols. Write standard operating procedures and reports. Maintain records of work performed, including results and methodology; utilizing records may calculate, graph, and compile data. Develop
-
to research protocols, supporting data collection, and maintaining a safe environment for participants and staff. Educate participants on exercise principles, device usage, and protocol adherence; communicate
-
modify protocols. Write standard operating procedures and reports. Maintain records of work performed, including results and methodology; utilizing records may calculate, graph, and compile data. Develop
-
, State, and Local Regulations, IRB requirements, consent form and protocol development. Good Clinical Practice (GCP) and Health Information Portability and Accountability ACT (HIPAA)-to be provided by COH
-
drug development, with strong potential for publication in high-impact journals. Our research aims to uncover fundamental mechanisms of leukemogenesis and solid tumor progression, with a particular
-
discovery approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer